Tina Xiang Lee MD PhD, DABFM (She/Her)
Geriatric Medicine, Preventive Medicine, Women's Health
PCP and owner, Bell Well Medical
Join to View Full Profile
4045 E Bell Rd Ste 134Phoenix, AZ 85032
Phone+1 602-569-2790
Fax+1 602-992-7851
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Tina Lee is a Family Medicine specialist based in Phoenix, AZ, with subspecialties in Geriatric Medicine, Preventive Medicine, and Women's Health. She completed her Family Medicine residency at Ohio State University Hospital in 2013, after earning her medical degree from the American University of Antigua College of Medicine in 2010. Dr. Lee currently owns and practices at Bell Well Medical and has previously worked at OhioHealth Riverside Methodist Hospital. She has experience in nutrition and has published research on a PDK-1 inhibitor's effects on vestibular and malignant schwannoma cells, which has been cited 43 times. She received CMS Meaningful Use Stage 1 Certification from NextGen Healthcare in 2013.
Education & Training
Ohio State University HospitalResidency, Family Medicine, 2010 - 2013
American University of Antigua College of MedicineClass of 2010
Certifications & Licensure
AZ State Medical License 2021 - 2028
OH State Medical License 2010 - 2022
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014-2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2014-2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Publications & Presentations
PubMed
- 47 citationsGrowth Inhibitory and Anti-Tumour Activities of OSU-03012, a Novel PDK-1 Inhibitor, on Vestibular Schwannoma and Malignant Schwannoma CellsTina X. Lee, Mark D. Packer, Jie Huang, Elena M. Akhmametyeva, Samuel K. Kulp
European Journal of Cancer. 2009-06-01
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
